University of Oslo, Oslo, Norway.
Oslo University Hospital, Oslo, Norway.
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211058678. doi: 10.1177/15347354211058678.
Preoperative hypnosis has shown promising effects in controlling side effects from breast cancer surgery, but the feasibility and effects are largely unknown outside the US.
A mixed-methods approach was applied involving a large-scale population survey and a small-scale pilot study. The survey assessed attitudes toward hypnosis in a representative sample from the general population (n = 1049), while the pilot study involved interviews with 5 women who received hypnosis prior to mastectomy/lumpectomy.
In the survey, 8% reported to have previous experience with hypnosis, and 67% reported willingness to accept hypnosis in a medical setting. Increasing age was associated with more skepticism, while previous experience was associated with less skepticism. In the pilot study, 4 themes were identified: (1) caretaking, (2) experiences related to hypnosis, (3) thoughts and feelings related to diagnosis, and (4) surgery. All participants reported positive experiences related to hypnosis, and none described unpleasant side effects or postoperative pain (pain intensity > 3) after surgery.
The results indicate that the general public is positive toward clinical hypnosis as a supplement to medical treatment and that preoperative hypnosis is feasible in Norwegian breast cancer patients.
ClinicalTrials.gov Identifier: NCT04300283.
术前催眠已显示出在控制乳腺癌手术副作用方面的良好效果，但在除美国以外的其他国家，其可行性和效果在很大程度上尚不清楚。
采用混合方法，包括一项大规模的人群调查和一项小规模的试点研究。该调查评估了一般人群代表性样本（n=1049）对催眠的态度，而试点研究则涉及对 5 名在乳房切除术/肿块切除术之前接受过催眠的女性进行访谈。
在调查中，8%的人报告有过催眠的经历，67%的人报告愿意在医疗环境中接受催眠。年龄越大，对催眠的怀疑态度越强烈，而之前的经验与怀疑态度的减少有关。在试点研究中，确定了 4 个主题：（1）护理，（2）与催眠相关的经历，（3）与诊断相关的想法和感受，（4）手术。所有参与者均报告了与催眠相关的积极体验，且没有人描述在手术后出现不愉快的副作用或术后疼痛（疼痛强度>3）。
结果表明，公众对临床催眠作为医疗治疗的补充持积极态度，且术前催眠在挪威乳腺癌患者中是可行的。
ClinicalTrials.gov 标识符：NCT04300283。
